• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Market Movers
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2024
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2024
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Fund Expert
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

Nestle India Q1CY24 Quarter Results

Nestle India reported 9% YoY revenue growth
  • 29 Apr 2024
Read Full Article >
  • Nestle India reported 14% quarter-on-quarter (QoQ) increase in its consolidated revenues for the calendar year quarter ended March 2024 (Q1CY24). On a year-on-year (YoY) basis, it witnessed a growth of 9%.
  • Its expenses for the quarter were up by 11% QoQ and 5% YoY.
  • While the net profit increased by 43% QoQ, it was up by 27% on a YoY basis.
  • The earnings per share (EPS) of Nestle India stood at 9.7 during Q1CY24.

Nestle India Financial Statements for Q1CY24:

(Rs, crores) Q1CY23 Q4CY23 Q1CY24 QoQ (%) YoY (%)
Total income
4,864
4,631
5,294
14%
9%
Total expenses
3,874
3,637
4,054
11%
5%
Profit before tax
990
886
1,251
41%
26%
Tax
254
231
316
37%
24.3%
Profit after tax
737
656
935
43%
27%
Earnings per share
7.6
6.8
9.7

Key Highlights:

  • Net Profit: Increased by 26.8% to Rs 935 crore compared to Rs 737 crore in Q4FY23.
  • Revenue: Grew by 9% to Rs 5,294 crore from Rs 4,864 crore in the corresponding quarter of the previous year. This marked the first time Nestle India's domestic sales crossed the Rs 5,000 crore mark.
  • Confectionery: Delivered a strong performance, driven by KitKat. India became the second-largest market for the brand globally.
  • Beverage Business: Recorded robust performance.
  • Dividend: Nestle India has decided on a final dividend of Rs 8.50 per equity share

Management Commentary:

  • Nestle India has approved the launch of Nespresso in the country and looks forward to participating in selling and distributing Nespresso’s products.
  • Nestle India is also partnering with Dr. Reddy's Laboratories to launch a nutraceutical joint venture in India (Q2 FY 2024-25). The venture combines Nestle's global health products with Dr. Reddy's strengths in nutraceuticals and Indian market reach. This collaboration aims to be a major player in the Indian nutraceutical market.

Data Source: BSE, Company announcements

Disclaimer: The content of this post is intended solely for educational purposes and should not be regarded as financial advice. Past performance is not indicative of future results. The securities and assets mentioned serve purely as illustrations only and should not be taken as recommendations for investment. Please note that the information presented is compiled from several sources available on the internet. We strongly advise consulting with a qualified financial advisor prior to making any investment decisions. Read the full disclaimer here.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -

N
N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]